Delivery Order SPE2DB24D2018-SPE2DB25FWWQ7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,173.33 to AmerisourceBergen Drug Corp for the supply of Lonsurf (20 mg-8.19 mg tablets, quantity 60) under a firm fixed price contract type. The award, issued on September 2, 2025, with an ultimate completion date of September 23, 2025, represents a non-set-aside competitive procurement. This delivery order is executed under AmerisourceBergen's Indefinite Delivery Contract (IDC) designated SPE2DX with DLA Troop Support...
- The Defense Logistics Agency awarded a $5,078.30 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Lonsurf (15 mg-6.14 mg tablets) in quantities of 20 units. This contract represents a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 29, 2025. The delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of LONSURF (15 mg-6.14 mg tablets) in a quantity of 40 units, with a ceiling value of $5,124.17 and firm fixed pricing. This delivery order, which is not set-aside, is scheduled for completion by August 28, 2025, with performance occurring at the vendor's location in Conshohocken, Pennsylvania. The award represents a competitive procurement under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $12.7K to AmerisourceBergen Drug Corp for LONSURF 20 mg-8.19 mg tablets (60-count supply). This non-set-aside, firm fixed-price delivery order was awarded on July 24, 2025, with completion scheduled for August 14, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. LONSURF is a prescription oncology medication used in cancer treatment, reflecting the company's role...
- This is a $7,685.32 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LONSURF 15 MG-6.14 MG tablets, which are used for medical treatment. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a...
- AmerisourceBergen Drug Corp was awarded a competitively-bid delivery order by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of LONSURF (TAS-102) 15 mg-6.14 mg tablets in quantities of 20 units. This is a firm fixed price delivery order with a ceiling value of $5,078.30 and an ultimate completion date of September 23, 2025. The contract is performed at the company's corporate office location in Conshohocken, Pennsylvania. This award carries no set-aside designation and...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,092.24, is for the delivery of LONSURF 15 MG-6.14 MG tablets. The contract has an ultimate completion date of April 22, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for LONSURF (TAS-102) 20 mg-8.19 mg tablets in a quantity of 40 units, valued at $6,760.14 under a firm fixed price contract. This award, issued on September 10, 2025, with an ultimate completion date of October 1, 2025, carries no set-aside designation and represents a competitive delivery order. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. LONSURF is...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of LONSURF 20 MG-8.19 MG tablets. The $8,531.96 firm-fixed-price contract has an ultimate completion date of October 8, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive range of medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $6,378.67 firm fixed price delivery order is for the supply of the prescription medication Lonsurf 20 mg-8.19 mg tablets. The contract has an ultimate completion date of April 4, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA...
- SPE2DB24D2018Indefinite Delivery Contract
- SPE2DB24D2018-SPE2DB25FWWQ7Delivery Order
The Defense Logistics Agency awarded a $10,173.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of LONSURF (trifluridine/tipiracil) 20 mg-8.19 mg tablets in quantities of 60 units. This delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), is scheduled for completion by September 30, 2025, with performance at the vendor's Conshohocken, Pennsylvania facility. The award was made through competitive procedures with no set-aside designation, reflecting the company's demonstrated capability to meet federal pharmaceutical procurement requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, holds a significant $999.99 billion IDC with DLA Troop Support Medical that extends through December 2026 and serves as a comprehensive global pharmaceutical supply vehicle for military healthcare programs. This delivery order for LONSURF, an oncology medication, exemplifies the company's role in supplying specialty pharmaceuticals and medical commodities to support Defense Health Agency operations and other federal healthcare systems. The firm fixed-price structure and expedited completion timeline indicate urgent medical supply requirements for military or veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 9/9/25 |